期刊文献+

碳青霉烯类药物不敏感克雷伯菌院内感染调查报告

Investigation on nosocomial infection of carbapenem-nonsusceptible Klebsiella pneumoniae
原文传递
导出
摘要 目的调查分析碳青霉烯类药物不敏感肺炎克雷伯菌院内感染原因,制订措施降低院内感染率。方法采用回顾性分析和前瞻性调查相结合的方法,选取10例对碳青霉烯类药物不敏感肺炎克雷伯菌阳性的住院患儿,依据其临床症状、细菌耐药检测结果、入院时检验结果等进行详细流行病学调查。结果 10例住院患儿中4例排除碳青霉烯类药物不敏感肺炎克雷伯菌感染,分析原因可能存在样本污染;4例确诊为对碳青霉烯类药物不敏感肺炎克雷伯菌感染,其中2例为院内感染、2例排除院内感染;另有2例不能明确诊断为对碳青霉烯类药物不敏感肺炎克雷伯菌感染。结论碳青霉烯类药物不敏感肺炎克雷伯菌是引起院内感染的重要致病菌,应对其引起医院的足够重视。应坚持检验与调查相结合,寻根溯源,注重各接触环节隔离消毒,加强工作人员培训,提高院内感染控制意识。 Objective To investigate the reason of nosocomial infection for carbapenem-nonsusceptible Klebsiella pneumoniae, and develop measures to reduce nosocomial infection. Methods Adopting the combination method of retrospective analysis and prospective investigation, 10 cases of hospitalized children with carbapenem-nonsusceptible Klebsiella pneumoniae were chosen and done a detailed epidemiological investigation on the basis of clinical symptoms, bacterial drug resistance test results, test results on admission, etc. Results 4 cases were excluded from the infection of carbapenem-nonsusceptible Klebsiella pneumoniae with the possible cause of sample contamination; 4 cases were diagnosed to be infected with carbapenem-nonsusceptible Klebsiella pneumoniae with 2 cases of nosocomial infection and 2cases excluded from nosocomial infection; another 2 cases could not be diagnosed to be infected with carbapenem-nonsusceptible Klebsiella pneumoniae. Conclusion We should adhere to the combination of inspection and investigation, pay attention to the isolation and disinfection of each contact link, strengthen the training of staff, improve the awareness of nosocomial infection control.
出处 《中国城乡企业卫生》 2017年第4期45-47,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
关键词 院内感染 碳青霉烯类药物不敏感肺炎克雷伯菌 调查 Nosocomial infection Carbapenem-nonsusceptible Klebsiella pneumoniae Intervention
  • 相关文献

参考文献5

二级参考文献48

  • 1吴昊.铜陵地区产ESBLs大肠埃希菌、肺炎克雷伯菌的检测及耐药性分析[J].安徽医学,2005,26(5):358-360. 被引量:3
  • 2叶应妩,王毓三,申子瑜,等.全国临床检验操作规程[M].第3版,南京,东南大学出版社,1996:890-920.
  • 3Yang Q,Wang H,Sun al. Phenotypic and genotypic charac-terization of Enterobacteriaceae with decreased susceptibility to car-bapenems: results from large hospital-based surveillance studies inChina[J]. Antimicrob Agents Chemother,2010,54(1) :573-577.
  • 4Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing;Twenty-Third Informational Supplement[S].2012.33.
  • 5Caijc,Zhou HW,Zhang R,et al.Emergence of Serratiamarcescens,Klebsiellapneumoniae,and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2in intensive care units of a Chinese hospital[J].Antimicrob Agents Chemother,2008,52(6):2014-2018.
  • 6Souli M,Galani I,Antoniadou A,et al. An outbreak of infectiondue to beta-Lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital : molecu-lar characterization,epidemiology,and outcomes[ J]. Clin InfectDis,2010,50: 364 -373.
  • 7M100-S23,Performance standards for antimicrobial susceptibility tes-ting; twenty-third informational supplement [ S ]. Wayne,PA: NC_CLS, CLSI document ,2013.
  • 8Munoz-Price LS,Poirel L,Bonomo RA,et al. Clinical epidemiolo-gy of the global expansion of Klebsiella pneumonia carbapenemas-es[ J]. Lancet Infect Dis,2013,13 :785 -796.
  • 9Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectalcaniage of blakpc producing caii>apenem-resistant enterobacteri-aceae :who is prone to become clinically in?ected[ J]. Clin Micro-biol Infect, 2013,19 ;451 -456.
  • 10Schwaber MJ,Carmeli Y. An ongoing national intervention to con-tain the spread of carbapenem-resistant enterobacteriaceae [ J ].Clin Infect Dis,2014,58:697 -703.

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部